Safety
diarrhea, fatigue, decreased appetite, hypertension, hand‐foot syndrome
ADVERSE EVENTS, HYPERTENSION
Treatment‐related adverse events (TRAEs) were observed in all 29 patients (100%). Common AEs (>40%) included fatigue (23/29; 79.3%), decreased appetite (17/29; 58.6%), and hand‐foot syndrome (13/29; 44.8%). The most frequently occurring (>10%) TRAEs greater than Grade 3 were hand‐foot syndrome (6/29; 20.7%), hypertension (5/29; 17.2%), and diarrhea (3/29; 10.3%) as indicated in Table Treatment‐related adverse events.